Skip to main content
SpringerLink
Log in

Biological DMARDs increase risk of acute coronary syndrome

  • Clinical study
  • Published:
Reactions Weekly Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Reference

  • Delcoigne B, et al. Short-term, intermediate-term and long-term risks of acute coronary syndrome in cohorts of patients with RA starting biologic DMARDs: results from four Nordic countries Annals of the Rheumatic Diseases : 22 Mar 2022. Available from: URL: http://doi.org/10.1136/annrheumdis-2021-221996

Download references

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Biological DMARDs increase risk of acute coronary syndrome. Reactions Weekly 1902, 5 (2022). https://doi.org/10.1007/s40278-022-13149-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s40278-022-13149-y

Search

Navigation